PHATHOM PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
PHATHOM PHARMACEUTICALS, INC. (PHAT) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 0 shares as of 2023-12-31, per its 10-K/A filed 2024-06-14.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2024-06-14
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 0.00 shares.
- 2023-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 0.00 shares.
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 0.00 shares.
- 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 31.84K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2023-12-31 | 0.00 shares 10-K/A · filed 2024-06-14 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 31.84K shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 254.44K shares 10-K/A · filed 2024-06-14 |
| 2022-09-30 | 477.03K shares 10-Q/A · filed 2022-11-09 |
| 2022-06-30 | 699.62K shares 10-Q · filed 2022-08-02 |
| 2022-03-31 | 922.21K shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 1.14M shares 10-K · filed 2023-02-28 |
| 2021-09-30 | 1.37M shares 10-Q · filed 2021-11-08 |
| 2021-06-30 | 2.14M shares 10-Q · filed 2021-08-10 |
| 2021-03-31 | 2.45M shares 10-Q · filed 2021-05-11 |
| 2020-12-31 | 2.75M shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 3.05M shares 10-Q · filed 2020-11-10 |
| 2020-06-30 | 3.35M shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 3.81M shares 10-Q · filed 2020-05-12 |
| 2019-12-31 | 4.24M shares 10-K · filed 2021-03-30 |
| 2019-09-30 | 4.46M shares 10-Q · filed 2019-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |